Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ARVN Arvinas Holding Company LLC

交易中 12-16 10:40:40 EST

12.00

-0.34

-2.76%

最高12.44	最低11.95	成交量15.42万
今开12.31	昨收12.34	日振幅3.97%
总市值7.71亿	流通市值7.71亿	总股本6,422万
成交额188.12万	换手率0.24%	流通股本6,422万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ARVN","market":"US","secType":"STK","nameCN":"Arvinas Holding Company LLC","latestPrice":12,"timestamp":1765899637370,"preClose":12.34,"halted":0,"volume":154162,"delay":0,"floatShares":64224294,"shares":64224294,"eps":-0.80523,"marketStatus":"交易中","change":-0.34,"latestTime":"12-16 10:40:40 EST","open":12.31,"high":12.44,"low":11.95,"amount":1881207.1286280002,"amplitude":0.039708,"askPrice":12.01,"askSize":200,"bidPrice":11.99,"bidSize":45,"shortable":3,"etf":0,"ttmEps":-0.80523,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1538020800000,"exchange":"NASDAQ","adjPreClose":12.34,"preHourTrading":{"tag":"盘前","latestPrice":12.18,"preClose":12.34,"latestTime":"09:25 EST","volume":550,"amount":6799.5004,"timestamp":1765895146473},"postHourTrading":{"tag":"盘后","latestPrice":12.26,"preClose":12.34,"latestTime":"19:54 EST","volume":175509,"amount":2165185.64,"timestamp":1765846483560},"volumeRatio":0.82668,"impliedVol":0.646,"impliedVolPercentile":0.204},"requestUrl":"/m/hq/s/ARVN/wiki","defaultTab":"wiki","newsList":[{"id":"1163182464","title":"Arvinas公布有关Vepdegestrant（Arv-471）临床开发项目的数据展示，参加2025年圣安东尼奥乳腺癌研讨会（Sabcs）","url":"https://stock-news.laohu8.com/highlight/detail?id=1163182464","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163182464?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:02","pubTimestamp":1763985764,"startTime":"0","endTime":"0","summary":"Arvinas公布有关Vepdegestrant（Arv-471）临床开发项目的数据展示，参加2025年圣安东尼奥乳腺癌研讨会（Sabcs）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","IE000M9KFDE8.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4592","SG9999002232.USD","IE00BLSP4239.USD","LU1023059063.AUD","LU1057294990.SGD","BK4588","LU0868494617.USD","LU0289739699.SGD","IE0002270589.USD","SG9999001176.USD","LU1066053197.SGD","LU1883839398.USD","BK4581","LU0225284248.USD","IE00BBT3K403.USD","LU0306807586.USD","SG9999003800.SGD","ARVN","BK4533","BK4568","LU0321505868.SGD","LU0306806265.USD","LU1894683264.USD","SG9999001176.SGD","LU1894683348.USD","BK4599","SG9999013999.USD","LU0170899867.USD","BK4550","LU0321505439.SGD","IE00BLSP4452.SGD","LU0122379950.USD","SG9999002224.SGD","SG9999011175.SGD","BK4007","IE00B19Z3B42.SGD","LU0985481810.HKD","LU1066051498.USD","PFE","LU0234572021.USD","LU0225771236.USD","LU0456855351.SGD","BK4534","BK4585"],"gpt_icon":0},{"id":"1171799889","title":"Arvinas第三季度收入为4190万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1171799889","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171799889?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:41","pubTimestamp":1763570505,"startTime":"0","endTime":"0","summary":"11月5日 - Arvinas第三季度运营开支为8570万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2568942697","title":"创新药重磅! Arvinas(ARVN.US)携辉瑞(PFE.US)推进“乳腺癌ER降解剂”第三方商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=2568942697","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568942697?lang=zh_cn&edition=full","pubTime":"2025-09-18 14:32","pubTimestamp":1758177173,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，美国生物科技新势力Arvinas以及合作伙伴医药巨头辉瑞已决定将重磅创新药vepdegestrant 的商业化权利对外授权——即决定将该药物的商业化权利对外转授权，该药是一种用于乳腺癌的在研雌激素受体蛋白降解剂。据了解，Arvinas 在一份新闻稿中表示，授权交由第三方的商业化举措“是释放vepdegestrant的全部价值并确保若获监管机构批准即可及时向市场供应的最佳前进路径”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3d5e617fa4201a4d118497eca86af802","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346711.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1023059063.AUD","BK4585","LU1883839398.USD","BK4534","BK4533","SG9999001176.SGD","LU0868494617.USD","BK4568","LU0225771236.USD","IE000M9KFDE8.USD","BK4588","LU1066051498.USD","SG9999013999.USD","PFE","SG9999003800.SGD","BK1574","IE0002270589.USD","LU0306806265.USD","LU0289739699.SGD","SGXZ57979304.SGD","LU0122379950.USD","IE00BLSP4452.SGD","IE00BLSP4239.USD","LU0234572021.USD","BK4550","LU0306807586.USD","ARVN","IE00BBT3K403.USD","BK4599","LU0058720904.USD","LU0170899867.USD","LU0321505439.SGD","LU1066053197.SGD","SG9999002232.USD","SG9999001176.USD","LU0456855351.SGD","SG9999011175.SGD","LU1894683348.USD","BK4007","BK1161","LU1057294990.SGD","06978","LU0985481810.HKD","159992","IE00B19Z3B42.SGD","BK4592","LU1894683264.USD","LU0225284248.USD","LU0321505868.SGD","BK4581"],"gpt_icon":1},{"id":"1100330847","title":"Logos Global Management致信敦促Arvinas董事会允许公司估值围绕核心科技重新定位，实施1:5反向股票分割","url":"https://stock-news.laohu8.com/highlight/detail?id=1100330847","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100330847?lang=zh_cn&edition=full","pubTime":"2025-08-23 06:07","pubTimestamp":1755900434,"startTime":"0","endTime":"0","summary":"Logos Global Management致信敦促Arvinas董事会允许公司估值围绕核心科技重新定位，实施1:5反向股票分割","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"1127436736","title":"Logos Global Management敦促Arvinas董事会向股东返还7亿美元资本","url":"https://stock-news.laohu8.com/highlight/detail?id=1127436736","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127436736?lang=zh_cn&edition=full","pubTime":"2025-08-23 06:06","pubTimestamp":1755900373,"startTime":"0","endTime":"0","summary":"Logos Global Management在致信中敦促Arvinas董事会向股东返还7亿美元资本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"1123281922","title":"Logos Global Management Lp在Arvinas持股比例升至8.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123281922","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123281922?lang=zh_cn&edition=full","pubTime":"2025-08-23 06:03","pubTimestamp":1755900194,"startTime":"0","endTime":"0","summary":"根据SEC文件显示，Logos Global Management Lp在Arvinas的持股比例从6月9日的6.4%增至8月15日的8.6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2558666056","title":"Arvinas, Inc.盘中异动 股价大涨5.25%报6.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558666056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558666056?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:00","pubTimestamp":1754920844,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时00分，Arvinas, Inc.股票出现波动，股价大幅拉升5.25%。截至发稿，该股报6.62美元/股，成交量31.9187万股，换手率0.43%，振幅4.37%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.41%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122004494dccac2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081122004494dccac2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2557540560","title":"Arvinas, Inc.盘中异动 临近午盘急速下跌5.13%报6.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557540560","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557540560?lang=zh_cn&edition=full","pubTime":"2025-08-07 23:46","pubTimestamp":1754581577,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日23时46分，Arvinas, Inc.股票出现波动，股价大幅下跌5.13%。截至发稿，该股报6.10美元/股，成交量113.965万股，换手率1.56%，振幅8.32%。Arvinas, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807234617a47b55c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807234617a47b55c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"1174853732","title":"异动解读 | Arvinas股价盘中大跌11.96%，季度业绩低于预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1174853732","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174853732?lang=zh_cn&edition=full","pubTime":"2025-08-06 22:16","pubTimestamp":1754489784,"startTime":"0","endTime":"0","summary":"生物制药公司Arvinas今日盘中股价大幅下跌11.96%，主要原因是公司发布的季度财报未能达到市场预期。根据Arvinas公布的最新季度报告，截至6月30日的季度调整后每股亏损为0.84美元，虽然好于分析师平均预期的每股亏损1美元，但仍远低于去年同期的表现。尽管财报表现不佳，但华尔街分析师对Arvinas仍保持相对乐观态度。值得注意的是，Arvinas股价今年以来已累计下跌60.3%，显示出投资者对公司长期发展前景的担忧。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ARVN"],"gpt_icon":0},{"id":"2557237051","title":"Arvinas, Inc.盘中异动 股价大跌8.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557237051","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557237051?lang=zh_cn&edition=full","pubTime":"2025-08-06 21:32","pubTimestamp":1754487140,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日21时32分，Arvinas, Inc.股票出现波动，股价急速跳水8.02%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213221a478d86e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806213221a478d86e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2551623191","title":"Arvinas, Inc.盘中异动 下午盘急速下挫5.08%报7.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551623191","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551623191?lang=zh_cn&edition=full","pubTime":"2025-07-16 02:22","pubTimestamp":1752603749,"startTime":"0","endTime":"0","summary":"北京时间2025年07月16日02时22分，Arvinas, Inc.股票出现波动，股价大幅下挫5.08%。截至发稿，该股报7.47美元/股，成交量113.668万股，换手率1.56%，振幅7.24%。Arvinas, Inc.股票所在的生物技术行业中，整体跌幅为1.15%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716022229a6abae75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716022229a6abae75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2550780646","title":"Arvinas, Inc.盘中异动 急速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550780646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550780646?lang=zh_cn&edition=full","pubTime":"2025-07-11 02:25","pubTimestamp":1752171945,"startTime":"0","endTime":"0","summary":"北京时间2025年07月11日02时25分，Arvinas, Inc.股票出现波动，股价急速跳水5.16%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.76%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711022546953dbf24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711022546953dbf24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2550265692","title":"Arvinas, Inc.盘中异动 股价大跌5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550265692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550265692?lang=zh_cn&edition=full","pubTime":"2025-07-09 22:13","pubTimestamp":1752070422,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日22时13分，Arvinas, Inc.股票出现波动，股价大幅跳水5.24%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为1.34%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221343953c3e9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709221343953c3e9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2548885014","title":"Arvinas, Inc.盘中异动 急速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548885014","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548885014?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:11","pubTimestamp":1751386294,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时11分，Arvinas, Inc.股票出现波动，股价大幅上涨5.05%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为1.19%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001134a4c95435&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702001134a4c95435&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2545239411","title":"Arvinas, Inc.盘中异动 快速上涨5.00%报7.77美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545239411","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545239411?lang=zh_cn&edition=full","pubTime":"2025-06-24 22:46","pubTimestamp":1750776360,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日22时46分，Arvinas, Inc.股票出现波动，股价快速上涨5.00%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为1.09%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624224600978cfe79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624224600978cfe79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2542658343","title":"Arvinas, Inc.盘中异动 早盘快速上涨5.11%报8.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542658343","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542658343?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:24","pubTimestamp":1749565486,"startTime":"0","endTime":"0","summary":"北京时间2025年06月10日22时24分，Arvinas, Inc.股票出现波动，股价快速上涨5.11%。截至发稿，该股报8.23美元/股，成交量38.6386万股，换手率0.53%，振幅5.33%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610222447a70246d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610222447a70246d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0},{"id":"2518745334","title":"辉瑞乳腺癌新药Vepdegestrant研究喜忧参半，授权方Arvinas股价暴跌40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518745334","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518745334?lang=zh_cn&edition=full","pubTime":"2025-03-11 20:59","pubTimestamp":1741697953,"startTime":"0","endTime":"0","summary":"辉瑞公司的下一代乳腺癌治疗药物 vepdegestrant 在最后阶段的研究中取得了好坏参半的结果，未能延缓所有患者的癌症进展，但达到了针对具有特定基因突变的亚组患者的目标。","market":"us","thumbnail":"https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f874ded00c644297784368a7af94c8ae"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1260559.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0058720904.USD","LU1894683264.USD","SG9999001176.SGD","LU0234572021.USD","LU1057294990.SGD","LU0225284248.USD","IE000M9KFDE8.USD","BK4534","BK4592","BK4599","IE00B19Z3B42.SGD","LU0225771236.USD","LU1894683348.USD","SG9999011175.SGD","LU0456855351.SGD","BK4550","BK4585","LU1066051498.USD","LU0321505439.SGD","PFE","SG9999001176.USD","LU0306807586.USD","ARVN","LU0321505868.SGD","IE00B19Z3581.USD","BK4568","BK4581","BK4007","SG9999002232.USD","LU0170899867.USD","LU0306806265.USD","LU0868494617.USD","LU0985481810.HKD","LU1023059063.AUD","LU1066053197.SGD","LU0289739699.SGD","LU1883839398.USD","IE00BLSP4452.SGD","IE00BBT3K403.USD","BK4533","IE00BLSP4239.USD","LU0122379950.USD","SG9999013999.USD","SGXZ57979304.SGD","SG9999003800.SGD","IE0002270589.USD","BK4588","SG9999002224.SGD"],"gpt_icon":1},{"id":"2518495206","title":"Arvinas, Inc.盘中异动 下午盘股价大跌5.14%报17.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518495206","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518495206?lang=zh_cn&edition=full","pubTime":"2025-03-11 02:13","pubTimestamp":1741630432,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日02时13分，Arvinas, Inc.股票出现异动，股价急速下挫5.14%。截至发稿，该股报17.34美元/股，成交量57.7109万股，换手率0.84%，振幅6.04%。Arvinas, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102135298a2d48d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031102135298a2d48d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARVN","BK4007"],"gpt_icon":0},{"id":"2517693254","title":"花旗：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517693254","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517693254?lang=zh_cn&edition=full","pubTime":"2025-03-08 05:50","pubTimestamp":1741384237,"startTime":"0","endTime":"0","summary":"花旗：维持Arvinas(ARVN.US)评级，由中性调整至中性评级, 目标价由28.00美元调整至19.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/08055048605286.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ARVN"],"gpt_icon":0},{"id":"2517194729","title":"Arvinas, Inc.盘中异动 下午盘急速拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517194729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517194729?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:38","pubTimestamp":1741289911,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时38分，Arvinas, Inc.股票出现异动，股价急速拉升5.20%。Arvinas, Inc.股票所在的生物技术行业中，整体跌幅为0.75%。Arvinas, Inc.公司简介：Arvinas Inc 是一家总部位于美国的生物制药公司，致力于通过发现、开发和商业化降解致病蛋白质的疗法来改善患有使人衰弱和危及生命的疾病的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033831989ee96f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307033831989ee96f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ARVN"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.arvinas.com","stockEarnings":[{"period":"1week","weight":-0.0736},{"period":"1month","weight":0.1675},{"period":"3month","weight":0.6152},{"period":"6month","weight":0.6519},{"period":"1year","weight":-0.3672},{"period":"ytd","weight":-0.3563}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Arvinas, Inc.于2013年2月根据特拉华州法律成立。该公司是一家生物制药公司，致力于通过发现、开发和商业化治疗降低致病蛋白质来改善患有衰弱和危及生命的疾病的患者的生活。该公司使用他们的专有技术平台来设计针对嵌合体或PROTAC的蛋白水解，这些嵌合体旨在利用人体自身的天然蛋白质处理系统来选择性地和有效地降解和去除致病蛋白质。Arvinas Holding Company，LLC相信他们的靶向蛋白质降解方法是一种新的治疗方式，可能提供优于现有方式的独特优势，包括传统的小分子疗法和基于基因的药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.025374},{"month":2,"riseRate":0.571429,"avgChangeRate":0.011057},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.187738},{"month":4,"riseRate":0.571429,"avgChangeRate":0.096543},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.132272},{"month":6,"riseRate":0.857143,"avgChangeRate":0.012839},{"month":7,"riseRate":0.714286,"avgChangeRate":0.109648},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.06004},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.073956},{"month":10,"riseRate":0.5,"avgChangeRate":0.007881},{"month":11,"riseRate":0.75,"avgChangeRate":0.171233},{"month":12,"riseRate":0.5,"avgChangeRate":0.353855}],"exchange":"NASDAQ","name":"Arvinas Holding Company LLC","nameEN":"Arvinas Holding Company LLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Arvinas Holding Company LLC(ARVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Arvinas Holding Company LLC,ARVN,Arvinas Holding Company LLC股票,Arvinas Holding Company LLC股票老虎,Arvinas Holding Company LLC股票老虎国际,Arvinas Holding Company LLC行情,Arvinas Holding Company LLC股票行情,Arvinas Holding Company LLC股价,Arvinas Holding Company LLC股市,Arvinas Holding Company LLC股票价格,Arvinas Holding Company LLC股票交易,Arvinas Holding Company LLC股票购买,Arvinas Holding Company LLC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Arvinas Holding Company LLC(ARVN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Arvinas Holding Company LLC(ARVN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}